Fig 1.
Study design and period.
Table 1.
Baseline characteristics and outcomes of study participants.
Fig 2.
Hazard ratio for exacerbation according to COPD medication.
Fig 3.
Hazard ratio for exacerbation according to period of medication use.
Table 2.
Clinical outcomes according to the active ingredient of chronic obstructive pulmonary disease medication.